Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Genosafe


1 rue de l’Internationale – BP 40064
91002 EVRY Cedex – FRANCE
Phone: +33 1 69 47 11 57
Email: contact@genosafe.com

Serge BRAUN: President
Site Web >
Genosafe - Genopole's Company Genosafe - Genopole's Company

#Biomanufacturing / Pharmaceutical Services #Therapeutics

  • Advanced-therapy medicinal products (MTI-ATMP)
  • Gene therapy
  • Cell therapy
  • Vaccination

Field of Activity


GenoSafe is a full contract research and consulting organization specialized in evaluating the quality, safety and efficacy of innovative biological products. Our goal is to enable our clients to move their products along clinical development rapidly and efficiently. From late research steps to clinical phases, we bring a unique expertise for the completion of customized studies.

BACKGROUND
GenoSafe was incorporated in 2003 and became operational in 2004. Its two shareholders are Genethon and the French Muscular Dystrophy Association (AFMTelethon).
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
From the research phase through to the clinic, GenoSafe offers true project support in study design, analytical development and product testing in three main areas:

  • Preclinical studies (including biodistribution studies for gene transfer products).
  • Quality control of gene and cell therapy products for preclinical and clinical use.
  • Clinical Development: Follow-up of patients included in clinical trials.
  • Customized regulatory advice for the development, manufacturing and control of ATMPs.

CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS

  • GenoSafe’s European and North-American clientele is composed of biotech firms, pharmaceutical companies and academic labs.
  • GenoSafe is a SME partner in various French and European collaborative projects.
  • In compliance with GLP and GCP regulations.

COLLABORATIONS SOUGHT
Clients seeking a CRO to assess the safety, quality and efficacy of their biotherapeutic products, responding to their expectations in terms of Quality of Services (scientific and regulatory) and meeting timelines.

  • Further information

    Annual turnover: €5.2M
    34 staff members
    Strengths:
    scientific expertise in complementary fields (molecular biology, immunology, cell culture, virology), customized services, flexibility, ability to meet timelines, GLP and GCP compliance facilities: BSL1, BSL2 and BSL3 labs.
    Innovation assets:
    Customer support from the research phases through to the clinic.

    Other facts:

    The financial situation of Genosafe has been rated “H3” (strong) by the Banque de France.

     

Share
Genopole’s Companies

#Biomanufacturing / Pharmaceutical Services


In same field

Nutropy - Genopole's company

Nutropy

Nutropy develops gourmet French cheese alternatives that are more sustainable and better for our health and animal welfare.

Discover
STH Biotech - Genopole's company

STH Biotech

STH BIOTECH is developing an innovative cannabis-based process for the reliable and sustainable production of active compounds for the well-being and healthcare sectors.

Discover
Synovance - entreprise généopolitaine

Synovance

Synovance has developed a revolutionary synthetic genomics platform for the conception of robust industrial bioproduction strains.

Discover
DeepTope - Genopole's company

Deeptope

– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodies

Discover
Proteinea - Genopole's company

Proteinea

Production as a service (PaaS) platform capable of producing recombinant proteins & enzymes cheaper and on a scale.

Discover
Altar - entreprise génopolitaine

Altar

Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Yubsis - Genopole's company

Yubsis

Yubsis provides Biological Science Information Solutions. Our platform is designed for research organizations (Pharma, Biotech, academic lab) willing to improve real-time teamwork, optimize performance and accelerate innovation.

Discover
Yposkesi - Genopole's Company

Yposkesi

YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Discover
Watchfrog Laboratory - Genopole's company

WatchFrog

WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Discover
Texcell - Genopole's Company

Texcell

Texcell offers fully GLP- and GMP-compliant viral safety testing and immunomonitoring services.

Discover
Pymabs - Genopole's Company

Pymabs

R & D services in the field of transient expression of recombinant proteins in plants.

Discover
Hybrigenics - Genopole's company

Hybrigenics Services

Hybrigenics Services proposes fee-for-services R&D support and provides innovative technological platforms for i) protein interaction studies (protein-protein, drug-protein, mechanisms of action) and ii) selection and validation of VHH antibodies.

Discover
Eukarÿs - Genopole's company

Eukarÿs

By means of its autonomous messenger RNA synthesis platform, Eukarÿs develops 1) systems for the bioproduction of viruses and recombinant proteins and 2) preventative vaccines for viral infectious diseases and treatments in immuno-oncology.

Discover
ABOLIS - entreprise génopolitaine

Abolis Biotechnologies

Abolis develops custom-order microorganisms able to produce molecules of interest via fermentation for the health, nutrition, chemistry and cosmetics sectors.

Discover
View all >
With the support from